Telomir Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
Telomir Pharmaceuticals has a total shareholder equity of $3.0M and total debt of $7.9K, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are $3.5M and $486.6K respectively.
Key information
0.3%
Debt to equity ratio
US$7.90k
Debt
Interest coverage ratio | n/a |
Cash | US$3.27m |
Equity | US$3.02m |
Total liabilities | US$486.55k |
Total assets | US$3.50m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: TELO's short term assets ($3.5M) exceed its short term liabilities ($486.6K).
Long Term Liabilities: TELO has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: TELO has more cash than its total debt.
Reducing Debt: Insufficient data to determine if TELO's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TELO has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: TELO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 104.1% each year